Back to results
US 2015/0203570 A1Published application
Prevention and treatment of pain using antibodies to sphingosine-1-phosphate
AssigneeLpath, Inc.
InventorRoger A. SABBADINI
Life of this patent
Estimating the term…
Abstract
The present invention relates to use of anti-S1P agents, for example, humanized monoclonal antibodies, for prevention and/or treatment of pain, including neuropathic pain, hyperalgesia, allodynia, and chemotherapy-induced pain.
Claims5
A method of treating or preventing pain in a human subject, comprising administering to a human subject having or believed to be at risk of having pain an antibody or fragment thereof that binds and neutralizes S1P, thereby effecting treatment or prevention of pain.
Dependencies are inferred from the claim text.